Cell and gene therapies (CGT) are evolving at a rapid pace. Now, new aseptic processing solutions are being designed specifically for CGT applications, optimizing speed and efficiency while maintaining sterility.
Cells in small-volume Advanced Therapy Medicinal Products (ATMP) typically are preserved at ultra-low temperatures. To maintain product integrity and functionality, the single-use consumables used in cryopreservation must withstand temperatures down to -190°C to maintain product integrity through processing, storage and transport.
Learn about cryopreservation challenges, best practices and the latest advances in single-use products, including the new MicroCNX® Nano Series connectors, which are made to meet the rigorous demands of today’s CGT processes.
CPC set the industry standard for sterile connection technologies with its AseptiQuik® G Series. It now offers the first aseptic connector solutions designed specifically for cryopreservation in CGT applications, the MicroCNX® ULT Series.
MicroCNX sterile connectors are proven to deliver flexibility, ease of use, less downtime and increased reliability and cost efficiencies, which can make them a better choice for system designers and processors.
In Episode 2 hosted by Nik Ekman, Application Development Manager for CPC Biopharma, he invites Fred Parietti, Co-founder of Multiply Labs to discuss automation and robotics in cell therapy manufacturing.
Troy Ostreng, Senior Product Manager at CPC, presented on the main stage at BioProcess International (BPI) reviewing the challenges and costs associated with Cell and Gene Therapy Development.